| Literature DB >> 25257786 |
Lingchong Wang1, Xiangyu Wang2, Hao Wu3, Rui Liu4.
Abstract
Among the three main divisions of marine macroalgae (Chlorophyta, Phaeophyta and Rhodophyta), marine green algae are valuable sources of structurally diverse bioactive compounds and remain largely unexploited in nutraceutical and pharmaceutical areas. Recently, a great deal of interest has been developed to isolate novel sulfated polysaccharides (SPs) from marine green algae because of their numerous health beneficial effects. Green seaweeds are known to synthesize large quantities of SPs and are well established sources of these particularly interesting molecules such as ulvans from Ulva and Enteromorpha, sulfated rhamnans from Monostroma, sulfated arabinogalactans from Codium, sulfated galacotans from Caulerpa, and some special sulfated mannans from different species. These SPs exhibit many beneficial biological activities such as anticoagulant, antiviral, antioxidative, antitumor, immunomodulating, antihyperlipidemic and antihepatotoxic activities. Therefore, marine algae derived SPs have great potential for further development as healthy food and medical products. The present review focuses on SPs derived from marine green algae and presents an overview of the recent progress of determinations of their structural types and biological activities, especially their potential health benefits.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25257786 PMCID: PMC4178480 DOI: 10.3390/md12094984
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Biodiversity in three taxonomic categories (family, genus, and species) of the green seaweeds that globally used as bioresources to prepare sulfated polysaccharides.
| Families | Genus | Species |
|---|---|---|
| Monostromataceae | ||
| Ulvaceae | ||
| Capsosiphonaceae | ||
| Cladophoraceae | ||
| Bryopsidaceae | ||
| Halimedaceae | ||
| Caulerpaceae | ||
| Codiaceae | ||
Figure 1The pie chart of green seaweeds in genus category used as raw materials to prepare sulfated polysaccharides (SPs) (data were calculated from the available references).
Figure 2The morphology of some representative species of green seaweed in living.
The summary sheet on chemical and anticoagulant characterizations of SP extracts and/or fractions obtained from various green seaweeds.
| Species | Extraction-Fractionation Procedure | Chemical Characteristics | Anticoagulant Characteristics | Ref. |
|---|---|---|---|---|
| Extraction with water, purification by GPC (Sepharose 2B) and IEC (Sepharose CL-6B). | A high Mw of proteoglycan with 18.4% sulfate and two SP fractions with 10.2% and 7.5% sulfated contents. | Heparin cofactor II and antithrombin III activity. | [ | |
| Extraction with water at room temperature and purified by IEC and GPC. | Sulfated arabinan and arabinogalactan. | Effective in APTT and TT. | [ | |
| Extraction with water at room temperature and 100 ºC, Purification by IEC (2×) and GPC. | Crude SP with 72.7% of Glc, 17.3% of Ara and 10.0% of Gal in sugar composition, and with 32.6% of sulfate and 5.2% of protein. | Direct inhibition of thrombin activity. | [ | |
| Extraction with water at room temperature and 100 ºC, Purification by IEC (2×) and GPC. | Sulfated heterarabinan with 60% of sulfated degree. | Activation of HCII. Different HCII-binding site to that of heparin and dermatan sulfate. | [ | |
| Sulfated heterarabinan with 80% of sulfated degree. | ||||
| Sulfated arabinan with 80% of sulfated degree. | ||||
| Sulfated heterarabinan with 50% of sulfated degree. | ||||
| Extraction with water at room temperature and purification by IEC and GPC. | Crude SP with 89% of Gal and 11% of Glc in sugar composition, and with 7.8%of proteins | Inhibition of fibrin polymerization, did not inhibit coagulation enzymes such as factor Xa or thrombin. | [ | |
| Extraction with Cold water and precipitation with KCl, purification by IEC and GPC. | Sulfated arabinans. | Effective in PT, APTT and TT. | [ | |
| Sulfated arabinans and arabinogalactans. | ||||
| Extraction with water at room temperature and 90 °C. Purification by IEC. | Sulfated arabinans, galactans and/or arabinogalactans. | APTT, TT, dual effect anticoagulant, but pro-aggregant. | [ | |
| Similar structural units to those of | APTT, TT, more active than that from | |||
| Extraction with hot water and purification by chromatography | A high rhamnose-containing sulfated polysaccharide. | Six-fold higher anti-thrombin activity relative to heparin | [ | |
| Extraction with hot water and purification by anion exchange column chromatography | Two SP fractions had similar high contents of rhamnose, whereas their sulfate contents, sulfation positions, molecular sizes and linkage patterns of rhamnose residues were different. | Potent thrombin inhibitors mediated by heparin cofactor II, also mildly inhibitors of coagulation factor Xa by potentiating antithrombin III. | [ | |
| Extraction with hot water, purification by IEC and SEC, and degradation by H2O2. | Sulfated rhamnan and its five degraded fragments with different molecular weights. | APTT and TT prolonging activities, but no PT activity. | [ | |
| Extraction with hot water and purification by IEC and SEC. | High rhamnose-containing SP. | APTT and TT activities, mediated by heparin cofactor II. | [ | |
| Extraction with hot water and purification by IEC and SEC. | High rhamnose-containing SP with an average molecular weight of about 513 kDa. | High anticoagulant activities in APTT and TT. | [ | |
| Preparation with mild acid hydrolysis of crude SPs and purification by IEC and GPC. | Sulfated rhamnan with 33.6 kDa of average molecular weight. | APTT and TT activities, mediated by heparin cofactor II. | [ | |
| Extraction with hot water, purification by IEC and SEC. | Crude ulvan containing 23.04%–35.20% sulfate ester groups, 10.82%–14.91% uronic acid and 3.82%–4.51% protein. | APTT activity due to the direct inhibition of thrombin and the potentiation of heparin cofactor II. | [ | |
| hot water and further purified by IEC and SEC. | A high arabinose-containing SP with sulfate ester of 31.0%, and with 511 kDa of average molecular weight. | Effective in APTT and TT. | [ | |
| Extraction with hot water, purification by IEC and SEC, reaction with chlorosulfuric acid in formamide. | Low molecular weight of SPs with various DS. | Effective in APTT, TT. | [ | |
| Extraction by proteolytic digestion, fractionation by acetone and molecular sieving in Sephadex G-100. | Four fractions of sulfated hetergalactan with various sulfate/sugar ratio. | APTT and PT activities, APTT activity was similar to that of Clexane. | [ | |
| Extraction by proteolytic digestion, fractionation by IEC. | Crude SP and its three fractions. | Effective in APTT. | [ | |
| Extraction by proteolytic digestion, fractionation by IEC and GPC. | Three SP fractions with galactose as their main sugar unit and presence of sulfate ester, galactose-6-sulfate, uronic acid. | Being both thrombin and factor Xa target proteases inhabitation. | [ |
Chemical and antiviral properties of some SPs from green seaweeds.
| Rawmaterial of Green Seaweeds | Chemical Characteristics | Antivirus Characteristics | ||||
|---|---|---|---|---|---|---|
| Tested SPs | Sugar Constituents | Sulfated Degree | Cytotoxicity to Host Cells (CC50, μg/mL) | Anti-HSV-l activity (IC50, μg/mL) of SP by Two Means of Addition | ||
| Before Viral Infection | After Viral Infection | |||||
| SP1 | Rha, (Xyl, GlcA) | 0.2 | >10,000 | 49 | 58 | |
| SP2 | Rha | 0.7 | 4100 | 0.4 | 3.7 | |
| SP3 | Rha, (Xyl, Glu) | 0.5 | 4700 | 1.9 | 9.6 | |
| SP4 | Gal | 1.2 | 6400 | 0.65 | 3.4 | |
| SP5 | Gal, (Xyl, Man) | 0.4 | 6400 | 0.55 | 10 | |
| SP6 | Ga, (Xyl, Man) | 0.4 | >10,000 | 1.6 | 7.6 | |
| SP7 | Ara, Xyl, Glu | 0.4 | 7500 | 8.5 | 56 | |
| SP8 | Ara, Xyl, Glu | 0.4 | >10,000 | 1.9 | 18 | |
| SP9 | Ara, (Glu, Xyl) | 0.8 | >10,000 | 1.0 | 3.6 | |
| SP10 | Ara, (Xly) | 0.5 | 3300 | 0.86 | 5.1 | |
| SP11 | Ara | 0.8 | 900 | 0.38 | 3.6 | |
Abbreviation: Rha, rhamnose; Xyl, xylose; GlcA, glucuronic acid; Glu, glucose; Gal, galactose; Man, mannose; Ara, arabinose. Parentheses indicated minor components.
Antinociceptive activities of two sulfated polysaccharide from green seaweeds in Swiss mice.
| Rawmaterial of Green Seaweeds | Tested SPs | Time (Day) | Dosage | Analgesic Action | |||
|---|---|---|---|---|---|---|---|
| Inhibition in Acetic Acid-Induced Writhing Test (%) | Inhibition of Licking Times in Formalin Test (%) for the First Phase (Left Column) and Secondphase (Right Column) | Effectiveness in Hot-Plate Test | |||||
| Cc-SP2 | 14 | 3 | 57.0 | no | 68.95 | no | |
| 9 | 89.9 | 42.47 | 82.34 | yes | |||
| 27 | 90.6 | 52.1 | 84.61 | no | |||
| SP1 | 3 | 3 | 44.21 | no | 56.41 | no | |
| 9 | 47.72 | no | 72.08 | no | |||
| 27 | 90.87 | 51.61 | 83.48 | no | |||
Both Cs-SP2 and SP1 were intravenously injected into Swiss mice in a prevented administration manner. The letter “no” means ineffectiveness while “yes” is effectiveness.
Figure 3Structure of some main repeating unit sequences found in ulvan.
Figure 4Some possible structural unit sequences found in galactans biosynthesized by Codium seaweeds.
Chemical composition and average molecular weight of SP fractions obtained from Caulerpa cupressoides.
| SP | Yield (%) | Total Sugar Content (%) | Sulfate Content (%) | Sulfated Degree (%) | Molecular Weight (kDa) | Molarratio of Monosaccharide Composition | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gal | Glu | Man | Xyl | Rha | Fuc | ||||||
| CCB-F0.3 | 13.43 | 54.91 | 34.63 | 0.63 ± 0.02 | 155 ± 10 | 1.0 | 0.1 | 0.2 | 0.1 | - | - |
| CCB-F0.5 | 46.91 | 52.38 | 38.05 | 0.73 ± 0.04 | 130 ± 10 | 1.0 | - | 0.1 | tr | - | - |
| CCB-F1.0 | 39.23 | 76.47 | 17.95 | 0.23 ± 0.01 | 155 ± 10 | 1.0 | tr | 0.1 | 0.6 | tr | - |
| CCB-F2.0 | 0.43 | 59.60 | 31.64 | 0.53 ± 0.02 | 170 ± 10 | 1.0 | 0.6 | 1.8 | 1.0 | 0.5 | 1.0 |
“-” means not detected; “tr” indicates traces.
Figure 5The main backbone structures of some typical sulfated mannans isolated from green seaweeds. (a) common mannan; (b) sulfated mannan from Codium vermilara; (c) sulfated mannan from Codium fragile; (d) sulfated mannan from Capsosiphon fulvescens.